Electronic capsule, in-vitro controller and noninvasive detection system

By designing an oral-friendly electronic capsule with built-in pressure and temperature sensors, using wireless signals to transmit data and equipped with alarm equipment, the problem of detecting intraperitoneal pressure pain and limited accuracy in the prior art is solved, and non-invasive and accurate Intraperitoneal pressure and temperature detection supports clinical diagnosis and can be used to monitor other physiological parameters.

CN221963586UActive Publication Date: 2024-11-08苏晓虎
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202323277344.0
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Priority Date
2023-08-25
Filing Date
2023-12-01
Publication Date
2024-11-08
Estimated Expiration
2033-12-01

AI Technical Summary

Technical Problem

The methods for detecting intraperitoneal pressure (IAP) in the prior art mainly rely on invasive methods, which have problems of pain and limited accuracy, especially the direct measurement method causes pain to the patient through puncture into the abdominal cavity, while the indirect measurement method Limited accuracy.

Method used

An electronic capsule is designed to enter the digestive tract through oral means, with built-in pressure sensors and temperature sensors, and uses wireless signals to transmit data to the external controller to achieve non-invasive detection of intraabdominal pressure and temperature, and is equipped with alarm equipment. If abnormalities are detected, they are instantly Call the police.

Benefits of technology

Achieve non-invasive, painless and safe detection of intraperitoneal pressure and temperature, providing accurate physiological data to support clinical diagnosis, and replace sensors for monitoring other physiological parameters such as gastrointestinal surface conditions, improving the safety of detection and accuracy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN221963586U_ABST
    Figure CN221963586U_ABST
Patent Text Reader

Abstract

The embodiment of the utility model provides an electronic capsule, an in-vitro controller and a non-invasive detection system. IAP can be obtained. The electronic capsule comprises: a housing having a shape similar to a medicine capsule so as to be swallowed into the abdomen from the oral cavity; the sensor comprises a pressure sensor and is used for obtaining pressure; a storage unit; a transmission unit; the controller is used for collecting data of the sensor and controlling the transmission unit to transmit the data; the battery is used for supplying power to the transmission unit, the sensor, the storage unit and the controller; the battery, the transmission unit, the sensor, the storage unit and the controller are integrated together to form a shape matched with the inner wall of the shell, and insulating liquid is filled between the shape and the shell so that pressure outside the shell can be transmitted to the pressure sensor through the insulating liquid. The electronic capsule can obtain various human body physiological data, such as IAP, temperature and gastrointestinal surface conditions, thereby providing an important basis for clinicians to evaluate health conditions of a plurality of systems and organs of a human body.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to a detection technology, in particular to an electronic capsule used for detecting abdominal cavity pressure and / or temperature. Background Art

[0002] Abnormal intra-abdominal pressure (IAP) is associated with many types of diseases. Generally speaking, normal IAP is: 0-5mm Hg; intra-abdominal hypertension (IAH) is IAP ≥ 12mmHg; abdominal compartment syndrome (ACS) is IAP ≥ 20mm Hg, at which time one or more organ failure may occur.

[0003] In the medical field, abnormal intra-abdominal high pressure (IAH) is often one of the direct causes of death. In the field of internal medicine, this figure is 54.4%, while in the field of surgery, it can be as high as 65%. The following is a brief description of the relationship between IAP and various systems and organs of the human body.

[0004] Relationship between IAP and cardiovascular system

[0005] An increase in IAP can cause a decrease in cardiac output, especially when IAP ≥ 20 mmHg, the cardiac output is significantly reduced; although the peripheral vascular resistance index is significantly increased, there is no obvious change in systemic blood pressure, while the pulmonary artery blood pressure, central venous pressure, and pulmonary capillary wedge pressure gradually increase; if intravenous infusion is given for resuscitation at this time, compared with before resuscitation, the systemic blood pressure will increase significantly, the central venous pressure will also increase accordingly, but the peripheral vascular resistance index will decrease significantly.

[0006] Relationship between IAP and respiratory system

[0007] When ACS occurs, the diaphragm will rise, the lung volume will decrease, the compliance will decrease, and the ventilation and gas exchange functions will be impaired, with clinical manifestations of dyspnea and hypoxia. IAP can reduce the pH value of arterial blood, increase the partial pressure of CO2, and reduce the blood HCO3 concentration. The damage to lung function caused by ACS is not only caused by IAH. In secondary ACS, lung ischemia / reperfusion injury is also one of the important mechanisms that impair lung function.

[0008] Relationship between IAP and urinary system

[0009] Oliguria and anuria are prominent clinical manifestations of ACS. Adverse effects on renal function include prerenal and renal factors. Prerenal factors refer to impaired cardiac function. Reduced cardiac output leads to reduced renal blood flow, reduced renal injection pressure and glomerular filtration rate. Renal factors refer to the damage to renal function caused by increased renal venous pressure and renal parenchymal pressure. Increased IAP compresses the renal vein and causes renal congestion, resulting in reduced glomerular filtration rate and increased plasma renin activity and aldosterone concentration.

[0010] Relationship between IAP and abdominal organs

[0011] When lAP increases, liver blood flow decreases, including hepatic artery, portal vein and microvascular blood flow. At the same time, mesenteric artery blood flow, intestinal mucosal blood flow and gastric, duodenum, jejunum, pancreatic and splenic artery perfusion are all reduced.

[0012] Relationship between IAP and the central nervous system

[0013] The increased intrathoracic pressure and CVP caused by IAH obstruct the intracranial venous return, causing increased intracranial pressure and decreased cerebral perfusion pressure, which may cause psychiatric symptoms clinically.

[0014] In summary, IAP can reflect the disease conditions of multiple systems and the condition of organs in the human body. However, in the prior art, IAP can only be obtained through invasive methods. For example, there are two methods for detecting IAP in the prior art:

[0015] 1. Indirect measurement method (cystometry): a catheter is placed in the human bladder, the patient is asked to empty the urine in the bladder, 50-100 ml of saline is injected, and the catheter is connected to the pressure sensor. When the patient lies completely flat, the mid-axillary line is taken as the zero point to eliminate the influence of abdominal muscle contraction, and the value at the end of expiration is taken. Therefore, the accuracy is limited.

[0016] 2. Direct measurement method: The pressure sensor is directly inserted into the abdominal cavity for measurement, which will undoubtedly cause pain to the patient. Utility Model Content

[0017] An embodiment of the utility model provides an electronic capsule, through which IAP can be obtained.

[0018] The embodiment of the utility model provides an electronic capsule, which comprises:

[0019] The outer shell is shaped like a medicine capsule so that it can be swallowed from the mouth into the stomach;

[0020] A sensor, which is arranged inside the housing, comprises a pressure sensor, wherein the pressure sensor is used to obtain pressure;

[0021] a storage unit, which is disposed inside the housing and is used to store the pressure obtained by the pressure sensor;

[0022] a transmission unit, which is disposed inside the housing and is used to transmit the pressure obtained by the pressure sensor;

[0023] A controller is disposed inside the housing and is used to collect data from the sensor and control the transmission unit to transmit the data;

[0024] A battery, which is arranged inside the housing and is used to provide power to the transmission unit, the sensor, the storage unit, and the controller;

[0025] The battery, transmission unit, sensor, storage unit, and controller are integrated together to form an outer shape that is compatible with the inner wall of the shell. The size of the outer shape is slightly larger than the internal space of the shell so that it will not shake when placed in the shell. The space between the outer shape and the shell is filled with insulating liquid so that the pressure outside the shell can be transmitted to the pressure sensor through the insulating liquid.

[0026] The shell is made of polycarbonate and has elasticity.

[0027] The electronic capsule further comprises: a non-contact switch, so that when in use, the switch is turned on to enable the controller to work.

[0028] The sensor also includes a temperature sensor.

[0029] The utility model also provides an in vitro controller, including: a transmission unit, a controller, and an alarm device.

[0030] The transmission unit is used to receive the pressure obtained by the pressure sensor of the electronic capsule;

[0031] The controller is used to receive the pressure and temperature received by the transmission unit, and determine whether the obtained pressure and temperature are normal. If not, the alarm device is activated;

[0032] The alarm device is used for alarming.

[0033] The external controller is arranged in a tablet computer or a mobile phone.

[0034] The utility model also provides a non-invasive detection system, which comprises an electronic capsule and an in vitro controller.

[0035] The electronic capsule of the utility model can be used to non-invasively detect intra-abdominal pressure and temperature. The electronic capsule is taken orally, and the electronic capsule passes through the digestive tract to detect the pressure and temperature in the digestive tract. The electronic capsule uses the new chip 3D manufacturing technology to directly arrange the precisely positioned artificial intelligence (AI) chip, pressure sensor and temperature sensor, wireless signal generator and battery in the oral capsule; then the IAP value and temperature in the body are monitored in real time through the external controller 20, such as a computer or iPad, and an alarm is immediately issued once an abnormality occurs. The electronic capsule generally stays in the human body for a maximum of about 120 hours, and then is excreted with the stool. Therefore, the non-invasive detection method of the electronic capsule of the utility model has no side effects, no pain, and is very safe.

[0036] In addition, the sensor in the electronic capsule of the utility model can be replaced with other different sensors, so different physiological parameters can be monitored. For example, if a camera sensor is installed, the condition of the stomach and intestine surface can be obtained, so as to judge the condition of the stomach and intestine, which is helpful for the treatment of stomach and intestinal diseases.

[0037] In summary, the embodiments of the present invention can obtain a variety of human physiological data, such as IAP, temperature, and gastrointestinal surface conditions, through the electronic capsule, thereby providing clinicians with an important basis for evaluating the health of multiple systems and organs of the human body. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] Figure 1 The schematic diagram of the structure of the electronic capsule of the embodiment of the utility model is shown. DETAILED DESCRIPTION

[0039] In order to facilitate those skilled in the art to understand and implement the present invention, embodiments of the present invention are now described in conjunction with the accompanying drawings.

[0040] like Figure 1 As shown, an embodiment of the present invention provides a non-invasive detection system, which includes an electronic capsule 10 and an in vitro controller 20 .

[0041] The electronic capsule 10 comprises: a shell 100, which is similar in shape to a medicine capsule so that it can be swallowed from the mouth into the abdomen. The main body is generally a cylinder, and the two ends of the cylinder are connected to a round cap-shaped state. The dimensions are: length <20 mm, diameter <12 mm, weight <5 g. The material of the shell can be polycarbonate, which is elastic and has a pressure resistance of >60 kg; a sensor 101, which is arranged inside the shell, includes a pressure sensor and a temperature sensor, wherein the pressure sensor is used to obtain pressure, and its error range is: + / -0.5hPa (0.1mmHg), and the temperature sensor is used to obtain temperature, and its error range is: + / -1.0C; a storage unit 102, which is arranged inside the shell, and is used to store pressure data obtained by the pressure sensor and temperature data obtained by the temperature sensor; a controller 103, which is arranged inside the shell, and is used to collect data from the sensor 101 and transmit the collected data to the in vitro controller 20 through the transmission unit 104. For example, the controller 103 sends a signal at regular intervals such as 1 The pressure data of the pressure sensor is collected in milliseconds and the pressure data is temporarily stored. In this way, 10 pressure data can be collected in 10 milliseconds, and the 10 pressure values ​​are averaged as the pressure value at the current time and current position, and then the pressure value data is transmitted to the in vitro controller 20 through the transmission unit 104; the transmission unit 104 is used to transmit the pressure data obtained by the pressure sensor and the temperature data obtained by the temperature sensor to the in vitro controller 20. The transmission process adopts a wireless signal, which can pass through the human body. The communication protocol can be BLE5.2, the wireless transmission power is>5dBm (in compliance with FCC standards), the antenna efficiency is>-25dB (in salt water), and the signal transmission frequency can be set to: 6 times / minute; the battery 105 is arranged inside the shell, and is used to provide power to the transmission unit 104, the sensor 101, the storage unit 102, and the controller 103. The battery power is> / =16mAh, the effective working time is>120 hours, and the standby time after leaving the factory is>9 months. The battery 105, the transmission unit 104, the sensor 101, the storage unit 102, and the controller 103 are integrated together to form an outer shape 106 adapted to the inner wall of the housing 100. The size of the outer shape 106 is slightly larger than the internal space of the housing 100 so that it will not shake when placed in the housing 100. The space between the outer shape 106 and the housing 100 is filled with insulating liquid so that the pressure or temperature outside the housing 100 can be transmitted to the pressure sensor and the temperature sensor through the insulating liquid, so that the pressure sensor and the temperature sensor obtain the pressure value and temperature value of the current position. The electronic capsule also includes: a non-contact switch, such as a magnetic switch, an infrared switch, etc., so that the switch is turned on when in use to make the controller 103 work.

[0042] The in vitro controller 20 includes: a transmission unit 200, which is used to receive the pressure data obtained by the pressure sensor and the temperature data obtained by the temperature sensor transmitted by the transmission unit 104 of the electronic capsule 10, and transmit it to the controller 201; the controller 201 is used to determine whether the pressure value in the obtained pressure data and the temperature value in the temperature data are normal, and if not, the alarm device 202 is activated to alarm; the alarm device 202 is used to alarm. The in vitro controller 20 can be set in a tablet computer, a mobile phone and other devices. The controller 201 of the utility model can also run artificial intelligence analysis and diagnosis software to learn the relationship between pressure data and / or temperature data and a certain disease, so as to judge a certain disease condition based on the pressure data and / or temperature data, and provide effective data and help for clinicians or patients.

[0043] The following describes the method of using the electronic capsule 10. The patient orally takes the electronic capsule 10, and the electronic capsule 10 passes through the esophagus, stomach, small intestine, and large intestine in sequence, and then is discharged. The in vitro controller 20 can receive the pressure data and temperature data sent by the electronic capsule 10. The controller 201 analyzes these data, such as determining whether the obtained pressure and temperature data are normal. If not, the alarm device 202 is activated to alarm.

[0044] The electronic capsule 10 of the utility model can be used to non-invasively detect intra-abdominal pressure and temperature. The electronic capsule is taken orally, and the electronic capsule passes through the digestive tract to detect the pressure and temperature in the digestive tract. The electronic capsule uses the new chip 3D manufacturing technology to directly arrange the precisely positioned artificial intelligence (AI) chip, pressure sensor, wireless signal generator and battery in the oral capsule; then the IAP value in the body is monitored in real time through the external controller 20, such as a computer or iPad, and an alarm is immediately issued once an abnormality occurs. The electronic capsule 10 generally stays in the human body for a maximum of about 120 hours, and then is excreted with the stool. Therefore, the use of the electronic capsule of the utility model for non-invasive detection has no side effects, no pain, and is very safe.

[0045] In addition, the sensor in the electronic capsule of the utility model can be replaced with other different sensors, so different physiological parameters can be monitored. For example, if a camera sensor is installed, the condition of the stomach and intestine surface can be obtained, so as to judge the condition of the stomach and intestine, which is helpful for the treatment of stomach and intestinal diseases.

[0046] In summary, the embodiments of the present invention can obtain a variety of human physiological data, such as IAP, temperature, and gastrointestinal surface conditions, through the electronic capsule, thereby providing clinicians with an important basis for evaluating the health of multiple systems and organs of the human body.

[0047] Although the present invention is described by way of embodiments, those skilled in the art will appreciate that many modifications and variations may be made to the present invention without departing from the spirit and substance of the present invention. The scope of the present invention is defined by the appended claims.

Claims

1. An electronic capsule, characterized in that: It includes: The outer shell is shaped like a medicine capsule so that it can be swallowed from the mouth into the stomach; A sensor, which is arranged inside the housing, comprises a pressure sensor, wherein the pressure sensor is used to obtain pressure; a storage unit, which is disposed inside the housing and is used to store the pressure obtained by the pressure sensor; a transmission unit, which is disposed inside the housing and is used to transmit the pressure obtained by the pressure sensor; A controller is disposed inside the housing and is used to collect data from the sensor and control the transmission unit to transmit the data; A battery, which is arranged inside the housing and is used to provide power to the transmission unit, the sensor, the storage unit, and the controller; The battery, transmission unit, sensor, storage unit, and controller are integrated together to form an outer shape that is compatible with the inner wall of the shell. The size of the outer shape is slightly larger than the internal space of the shell so that it will not shake when placed in the shell. The space between the outer shape and the shell is filled with insulating liquid so that the pressure outside the shell can be transmitted to the pressure sensor through the insulating liquid.

2. The electronic capsule according to claim 1, characterized in that: The shell is made of polycarbonate and has elasticity.

3. The electronic capsule according to claim 1, characterized in that: The electronic capsule further comprises: a non-contact switch, so that when in use, the switch is turned on to enable the controller to work.

4. The electronic capsule according to claim 1, characterized in that: The sensor also includes a temperature sensor.

5. An in vitro controller, characterized in that: include: Transmission units, controllers, alarm equipment, The transmission unit is used to receive the pressure obtained by the pressure sensor of the electronic capsule according to claim 1; The controller is used to receive the pressure received by the transmission unit and determine whether the obtained pressure is normal. If it is abnormal, the alarm device is activated; The alarm device is used for alarming.

6. The in vitro controller according to claim 5, characterized in that: The external controller is arranged in a tablet computer or a mobile phone.

7. A non-invasive detection system, characterized in that: The non-invasive detection system comprises: the electronic capsule described in claim 1 and the in vitro controller described in claim 5.

Citation Information

Cited By

  • Self-generating stomach residence electronic capsule and application thereof

    CN120267955A

  • A self-generating gastric-resident electronic capsule and its application

    CN120267955B